|
GB202102277D0
|
|
Immunoassay for detecting Eosinophilic Esophagitis
|
|
GB202100902D0
|
|
Calprotectin assay
|
|
GB202020399D0
|
|
Assay for detecting collagen XI biomarkers
|
|
GB202019578D0
|
|
Assay for detecting Collagen XVIII biomarkers
|
|
GB202017987D0
|
|
Biomarker of fibrosis
|
|
GB202014323D0
|
|
Assay for assessing cancer
|
|
WO2020245404A1
|
|
Assay for assessing heart failure
|
|
GB202005564D0
|
|
Biomarker of fibrosis
|
|
GB202004195D0
|
|
Type XIX collagen assay
|
|
US2020158726A1
|
|
Collagen Type X Alpha-1 Assay
|
|
GB201917819D0
|
|
A neo-epitope specific assay measuring protease mediated degradation of type iv collagen
|
|
WO2020065078A1
|
|
Type xi collagen assay
|
|
GB201912856D0
|
|
Assay for assessing heart failure
|
|
US2019309055A1
|
|
Immunoassay for Collagen Type VI
|
|
GB201903167D0
|
|
Fibrogenic peptides derived from collagen types VI, VII and XXVII
|
|
GB201901710D0
|
|
Collagen type 23 assay
|
|
GB201802070D0
|
|
Elastin assay
|
|
GB201721387D0
|
|
Tumstatin assay
|
|
GB201721308D0
|
|
SPARC assay
|
|
GB201717301D0
|
|
Type xvi collagen assay
|
